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Differential Characteristics of Olive Pollen Cultivars
■ Abstract
The olive tree is grown in many parts of the world. Its germplasm is very broad, with 250 varieties in Spain alone. Variations in the ability of pollen 
to germinate have been studied in detail and show conspicuous differences between varieties. However, commercial olive pollen from cultivars 
whose origin is unknown is the material that is commonly used for clinical and biological studies. We aim to assess the putative heterogeneity 
of olive cultivars with regard to the presence of several pollen allergens and to determine whether these differences have biological and clinical 
relevance. Previous studies show that most allergens isolated and characterized to date are highly polymorphic. Olive cultivars display wide 
differences in the expression levels of many allergens and in the number and molecular characteristics of the allergen isoforms expressed. These 
differences are maintained over the years, and are intrinsic to the genetics of each cultivar. Such broad polymorphism seems to be involved 
in the physiology of the olive reproductive system, which might include the adaptation of the plant to different environmental conditions, 
the establishment of the compatibility system, and pollen performance. The differences in allergen composition in cultivars, particularly in the 
Ole e 1 allergen, are responsible for the important differences in the allergenic potency of the extracts. These fi ndings could have a number 
of implications for the diagnosis and therapy of olive pollen allergy. We discuss how cultivar differences affect extract quality, diagnostic and 
therapeutic effi cacy and safety, and the development of new vaccines based on the use of recombinant allergens.
Key words: Allergens. Clinical test. Cultivar. Physiology. Olive. Pollen. Polymorphism. Variety.
 J Investig Allergol Clin Immunol 2007; Vol. 17, Supplement 1: 69-75© 2007 Esmon Publicidad
Differential Characteristics of Olive Pollen 
From Different Cultivars: Biological and 
Clinical Implications
JD Alché, AJ Castro, JC Jiménez-López, S Morales, A Zafra, 
AM Hamman-Khalifa,* MI Rodríguez-García
Department of Biochemistry, Cell and Molecular Biology of Plants, Estación Experimental del Zaidín, CSIC, 
Granada, Spain
* Department of Genetics, Faculty of Science, University of Granada, Granada, Spain
 Resumen
El olivo es un cultivo ampliamente representado en el mundo. Su germoplasma es muy amplio, con 250 variedades sólo en España. La capacidad 
del polen para germinar, que presenta notables diferencias entre variedades, ha sido estudiada en detalle. El material usado comúnmente 
para estudios clínicos y biológicos es, sin embargo, polen comercial de cultivares de origen desconocido. Nuestro objetivo es evaluar la posible 
heterogeneidad de los cultivares de olivo en relación a la presencia de varios alérgenos del polen, y determinar si esas diferencias tienen 
relevancia biológica y clínica. Estudios previos muestran que la mayor parte de los alérgenos aislados y caracterizados hasta la fecha son 
altamente polimórfi cos. Los cultivares de olivo muestran amplias diferencias en los niveles de expresión de muchos alérgenos, así como en el 
número y características moleculares de las isoformas alergénicas expresadas. Estas diferencias se mantienen a lo largo de años, y son intrínsecas 
a la genética de cada cultivar. Este amplio polimorfi smo parece estar implicado en la fi siología del sistema reproductivo del olivo, en relación 
con la adaptación de la planta a diferentes condiciones ambientales, el establecimiento de un sistema de compatibilidad, y el dinamismo del 
polen. Las diferencias en la composición alergénica de los cultivares, particularmente en cuanto al alérgeno Ole e 1, son responsables de las 
importantes diferencias en la potencia alergénica de los extractos. Estos hallazgos pueden tener numerosas implicaciones en la diagnosis y 
terapia de la alergia al polen del olivo. Discutimos cómo las diferencias entre cultivares afectan a la calidad del polen, a la efi cacia y seguridad 
del diagnóstico y la terapia, así como al desarrollo de nuevas vacunas basadas en el uso de alérgenos recombinantes.
Palabras clave: Alérgenos. Pruebas clínicas. Cultivar. Fisiología. Olivo. Polen. Polimorfi smo. Variedad.
JD Alché, et al
J Investig Allergol Clin Immunol 2007; Vol. 17, Supplement 1: 69-75 © 2007 Esmon Publicidad
70
Olive Germplasm and Its Classifi cation 
The olive tree was one of the earliest fruit crops to be 
domesticated. It spread from the Middle East towards the 
west of Europe approximately 6000 years ago [1,2]. Over 
time, a large number of cultivars have appeared due to 
events such as outcrossing, mutation, clonal selection, and 
selective pressure (including grower requirements) on the 
original olive germplasm. Controversy surrounds many other 
aspects of olive genetics including the putative origin of the 
species (supposed to be an allopolyploid), the phylogenetic 
relationships between Olea europaea and related Olea 
species, and between cultivated and wild forms of the 
olive [3,4]. Although 2600 different olive cultivars have 
been recorded [5], the number of olive cultivars throughout 
the world is uncertain. 
In Spain, olive cultivars were initially described in the fi rst 
century and have reappeared in historical documents until the 
present. Modern systematic classifi cations of olive cultivars 
were fi rst carried out in Andalusia [6] and later in other regions 
of Spain to provide a picture of the whole country, which 
includes 272 cultivars. Olive cultivars in Spain are spread 
throughout continuous regions, where they are predominant. 
Outside these regions their importance quickly decreases [4]. 
The classifi cation of olive germplasm is increasingly urgent as 
a requirement of modern cultivation strategies and the breeding 
and selection programmes currently in progress. Morphological, 
biometric, and agronomical characteristics have been widely 
used to describe olive cultivars. However, biochemical and 
molecular techniques are emerging as the preferred tools 
for cultivar identifi cation. They include isozymes, randomly 
amplifi ed polymorphic DNA markers, amplifi ed fragment 
length polymorphism markers, inter-simple sequence repeat 
markers, and, more recently, microsatellites [7].
Both sexual reproduction and asexual reproduction 
coexist in olive. Vegetative propagation is widely used for 
agronomical purposes and is one of the principal reasons for 
the marked genetic homogeneity occurring within cultivated 
varieties [8]. Sexual reproduction is the main physiological 
process responsible for olive production, and morphological 
parameters of the fruit, particularly of the endocarp, are 
widely used as key distinctive characteristics for olive 
cultivar discrimination [4,6]. Other characteristics of the 
reproductive organs, such as infl orescence length, shape, 
presence of supernumerary fl owers, and thickness of fl ower 
buds, have also been used for this purpose [6]. As for pollen 
grains, some authors have proposed pollen morphology as 
an additional tool for cultivar identifi cation, based on the 
sporophytic origin of the exine, its stability, independence 
from environmental conditions, and genetic control [7]. Few 
publications have made use of this approach to date, and 
information is limited [9,10]. 
One of the fi rst biochemical approaches applied for 
cultivar discrimination was the use of isozymes [11]. For 
this purpose, pollen rather than leaves was the material of 
choice, particularly because of its higher degree of enzyme 
polymorphism [12]. The analysis of isoenzymes has enabled 
several authors to discriminate successfully between the 
cultivars assayed using only a limited number of enzyme 
systems [11,13]. None of the authors observed intracultivar 
polymorphisms using these methods. 
Polymorphism Is a General Characteristic 
of Many Olive Pollen Allergens
Biochemical and molecular studies to characterize the 
allergenic proteins present in olive pollen have shown that 
polymorphism is a general feature. In this context, we can say 
that Ole e 1 presents a high degree of polymorphism in both 
its nucleotide and amino acid sequences [14-16]. Ole e 1 can 
be characterized as glycosylated (apparent molecular weight 
of 20 kDa), non-glycosylated (18.5 kDa), hyperglycosylated 
(22 kDa), and dimers of the glycosylated form (40 kDa), 
in addition to the diversity generated by the components 
of the glucidic chains [17]. For Ole e 2 (profi lin), some 
authors have shown the presence of heterogeneities in its 
sequence [18,19]. The protein possesses an average molecular 
weight of 15 kDa, and the analysis of a limited number of 
available sequences has shown heterogeneity in at least 4 
residues of the primary structure, with important implications 
Figure 1. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) (12%) and Western blot identifi cation of Ole e 1 and Ole e 2 
forms in crude pollen protein extracts from 4 olive cultivars. Panel A. 
Silver-stained gel. Panel B. Immunoblot tested with an anti-Ole e 1 
monoclonal antibody showing 1 to 3 cross-reactive bands with apparent 
molecular masses of 22.0, 20.0, and 18.4 kDa. Panel C. Immunoblot 
tested with a polyclonal serum to Ole e 2, showing up to 5 cross-reactive 
bands  with apparent molecular masses of 15.7, 14.9, 14.2, 13.7, and 
13.0 kDa apparent molecular masses. Thirty micrograms of total protein 
was loaded per lane.
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and the recombinant forms of the protein. For Ole e 7, a 
high degree of polymorphism has been demonstrated, with 
molecular weights ranging from 9.87 kDa to 10.29 kDa, 
and 2 isoforms have been characterized [22]. Ole e 9 
shows a relatively low (although still signifi cant) level of 
polymorphism, which has been detected by high-performance 
liquid chromatography and later confi rmed after nucleotide 
sequencing [24]. This polymorphism can be attributed to the 
presence of microheterogeneities in the peptide chain and/or 
the glycosylated moiety of the allergen, which presents 2 
putative N-glycosylation sites, as does Ole e 1. 
Allergen Polymorphism Is Closely Related 
to the Cultivar Origin of Olive Pollen 
Molecular evidence regarding the differential composition of 
the allergens in the pollens from different cultivars is beginning to 
emerge. Preliminary studies characterizing cDNA sequences of 
Ole e 1 in a limited number of cultivars showed the existence of 
a high number of microheterogeneities in the analyzed sequences. 
Software analysis of microheterogeneities showed that the 
intercultivar variability detected was higher than the intracultivar 
variability [25,26,unpublished results]. These studies are presently 
being extended to several characterized allergens in a signifi cant 
number of olive cultivars. The numerous sequences obtained have 
been sent to GenBank.
The analysis of the levels of expression of each allergen and 
its biochemical characteristics in the major olive cultivars is also 
beginning to be addressed. In addition to the well established 
differences in Ole e 1 expression (Figure 1), preliminary results 
regarding the expression and presence of sequence heterogeneities 
for Ole e 3, Ole e 5, and Ole e 6 are already available [26,27], 
indicating the presence of signifi cant differences between olive 
cultivars. Ole e 2 is also revealing itself as a relatively highly 
polymorphic allergen in cultivars, displaying at least 5 different 
isoforms (Figure 1). 
for the 3-D structure of the protein. A recent study describes 
cloning and sequencing of the complete form of Ole e 5 [20] 
(GenBank AJ428575). The sequence obtained, together with 
those already provided by different authors [21,22] (GenBank 
P80740, AF191342, AF426829), is well conserved, since the 
percentage of identity with Cu/Zn-superoxide dismutase from 
other plant sources ranges from 80% to 90%. However, all 
the aforementioned authors have described the presence of 
a remarkable degree of polymorphism in this olive protein. 
Thus, in preliminary work carried out by our group, we 
managed to detect and localize 4 isoforms of the enzyme in 
pollen of the variety “Picual,” displaying isoelectric points of 
4.60, 4.78, 5.08, and 5.22 [23]. Five isoforms of the protein 
were later described [21]. Butteroni et al [20] reported 
discrepancies between the amino acid sequences of the native 
Figure 3. Fluorescein diacetate test of pollen viability. Fluorescent pollen 
grains are considered viable (V), whereas nonfl uorescent pollen grains are 
considered nonviable (NV). Some pollen grains display slight fl uorescence, 
and are therefore considered partially viable only (PV).
Figure 2. Two-dimensional protein profiles of pollen from 2 olive 
cultivars (A: Picual, and B: Arbequina) after colloidal Coomassie staining. 
Conspicuous differences can be observed in both the quantitative 
expression and the isoform distribution of Ole e 1 allergen in both 
cultivars (arrows). 
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Figure 4. Olive pollen germination after culture in vitro for 5 hours. For 
statistical purposes, pollen grains are considered germinated when the 
length of the emerging pollen tube (arrows) is at least equal to the pollen 
grain diameter (approximately 30 μm). 
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Proteomic approaches are promising in this context. A 
recent study on a number of olive pollen extracts from different 
cultivars [28] detected signifi cant differences in their allergenic 
composition. Figure 2 shows 2-D profi les obtained from the 
pollen of 2 cultivars regarded as very different in their Ole e 1 
content.
Biological Implications of Allergen 
Polymorphism
Differences in pollen production and performance 
among cultivars are well documented [29]. Two major tests 
are widely used to assess pollen viability: the fl uorescein 
diacetate test [30] (Figure 3) and the determination of the 
germinability percentage after in vitro pollen culture [31] 
(Figure 4). Olive cultivars present wide differences regarding 
both parameters. 
In addition to their allergenic character, allergens are 
considered key proteins for pollen physiology. An important 
question is whether these biological functions might differ to 
some extent according to the cultivars. Although the function 
of many olive pollen allergens is well studied [17,32-34], a 
large amount of information is still lacking.  We can speculate 
that the presence of numerous forms for each of the proteins 
studied in the different varieties represents an adaptive 
advantage of the plant to different environmental conditions, 
which could explain the varying abilities of the pollen grains 
from different varieties to germinate, their different viability, 
or even the (self) incompatibility/(self) pollination ability 
of each variety [35]. It could also explain the existence of 
androsterile varieties or varieties with low/null pollination 
effi ciency [29]. Constitutive accumulation of ROS/H
2
O
2
 
appears to be a feature of angiosperm stigmas [36], which 
is discussed in terms of a possible role for pollen–stigma 
interactions and defense. Therefore, pollen antioxidant 
systems such as Ole e 5 may also play an important role in 
such processes. An increase in profi lin expression has also 
been described as a response to salinity in some species [37]. 
Many of these models can be tested using multidisciplinary 
approaches including biochemical, molecular, and cellular 
analysis of allergen expression.
Clinical Implications of Allergen 
Polymorphism
In the past 2 decades, several pioneering papers and 
research communications have established the presence of 
differences in the protein composition and allergenic activity 
of pollen extracts from different origins [38,39]. Studies 
carried out in Israel [40,41] using olive pollen extracts from 
autochthonous and foreign varieties showed sharp differences 
in the quantitative/qualitative allergenic composition of such 
extracts and the reactivity of patients’ sera. These authors 
suggested that multiple olive extracts should be used in order 
to improve the reliability of skin-prick tests, particularly 
in cases of questionable diagnosis where the patients have 
clinical evidence of olive-induced hay fever but do not have 
a positive skin-prick test response to one of the commonly 
used commercial extracts (10% of patients). Conspicuous 
differences were later observed in the reactivity of the sera 
from Spanish patients tested against protein extracts from 
Californian pollen [21]. Quantitative differences in the levels 
of certain allergens between extracts from different sources of 
pollen in Spain and California have also been described [42]. 
Further studies carried out in Spain [43-46] indicated that 
skin-prick test reactivity to olive pollen extracts varies 
greatly depending on the olive cultivar. Olive pollen extracts 
from different cultivars also possess differences in allergenic 
potency expressed in histamine equivalent prick units per gram 
of raw material [46]. These studies have made it possible to 
identify Ole e 1 as one of the major reasons for the differences 
reported to date (Figure 1), although the role of other allergens 
cannot be excluded. However, disparities in allergenic potency 
and Ole e 1 content have been maintained over the years, 
suggesting that they are due to genetic differences intrinsic 
to the cultivars [46].
Our increasing knowledge of the variability of allergenic 
molecules with respect to the genetic origin of the allergens 
is not exclusive to olive pollen allergens. Similar results 
have been obtained for other plant allergens, such as Phoenix 
dactylifera [47,48]. In apple (Malus domesticus), cultivars 
differ considerably in allergenicity [49,50]. The genetic basis 
of polymorphism of Mal d 1 (PR-10), Mal d 2 (thaumatin-
like protein), Mal d 3 (nonspecifi c lipid transfer protein), and 
Mal d 4 (profi lin) genes has been characterized [51-53]. In 
birch (Betula pendula), 13 Bet v 1 putative alleles have been 
characterized and their occurrence in different cultivars is a 
matter for future study [54].
The presence of such variability will undoubtedly involve 
a number of aspects of current clinical practice. Here, we 
suggest the main concerns that will need to be addressed by 
future research.
Pollen batches provided by different companies to 
extract manufacturers have been shown to vary widely in 
their total protein content, Ole e 1 content, and allergenic 
potency [55]. In addition, pollen samples commonly show 
large batch-to-batch variability in several parameters. 
In most cases, these pollen samples are obtained from 
undisclosed sources and, in general, no information 
regarding the cultivar origin is released. The discrepancies 
observed may be due to the use of different cultivars as 
the pollen source. Since reliability of pollen extracts used 
for clinical purposes is a major concern for clinicians, we 
suggest that such information should be considered as a 
major criterion for standardization. 
The main objective of pollen extracts should be to imitate 
as much as possible the composition of the panel of allergens 
to which the patient is normally exposed and is reactive. 
This can be achieved through increased specialization 
and personalization of the extracts used for diagnosis and 
immunotherapy, ie, discriminating the cultivar used for 
their preparation. The use of appropriately identifi ed and 
standardized pollen extracts from independent cultivars may 
also lead to more effi cacious diagnosis and immunotherapy, 
given that some patients have proven particularly sensitive to 
the extracts from specifi c cultivars [43,45]. 
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An additional advantage of extracts that have been 
well characterized by cultivar origin is their increased 
safety. Adjusting the extracts used for immunotherapy to a 
patient’s reactivity may help to avoid the undesirable de novo 
immunotherapy-induced sensitizations reported by some 
authors, even though these are relatively uncommon [56].
Novel diagnostic and therapeutic concepts often include 
the use of recombinant allergen molecules [57]. Recombinant 
allergens will undoubtedly offer tremendous advantages over 
conventional allergen-specifi c immunotherapy based on extracts 
from natural sources. However, in our opinion, a reduction in 
the number of allergenic structural entities in the extracts might 
result in substantial differences between these preparations and 
real exposure to an allergen in the patient’s environment, unless 
the recombinant molecules are carefully selected. As the number 
of isoforms for each allergenic protein represented in the different 
cultivars is being characterized, it would be interesting to include 
such information in the putative recombinant formulae. 
This strategy could be incorporated into practically all the 
new developments in allergy diagnosis and therapy, from the 
new high-throughput diagnosis systems to the preparation of 
hybrid molecules, use of allergen fragments, allergen multimers, 
and design of hypoallergens. For instance, detailed analysis 
of the reactivity of the natural isoforms of a given allergen 
in different cultivars, combined with the sequence analysis 
already under way, would help to design hypoallergens, thus 
complementing current strategies [58]. Moreover, further 
research on allergen variability through olive germplasm would 
prove that hypoallergenic and other allergenic forms with 
putative application in clinical practice are already available as 
natural allergens in some cultivar sources.
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